Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Etsuji Suehisa"'
Publikováno v:
Rinsho byori. The Japanese journal of clinical pathology. 62(11)
CK-MB activity, which is measured by the immunoinhibition method, is an important marker for use in the diagnosis of acute coronary syndromes. In the present study, we evaluated the basal performance of a recently improved CK-MB activity kit, "L-syst
Autor:
Masayuki Toku, Etsuji Suehisa, Emi Takeo, Yoshiaki Tomiyama, Sumiyuki Nishida, Sumiko Torita, Yoh Hidaka, Tomio Kawasaki
Publikováno v:
Blood Coagulation & Fibrinolysis. 22:185-189
The Nijmegen assay for the factor VIII (F-VIII) inhibitor is recommended by the International Society on Thrombosis and Haemostasis/Scientific and Standardization Committee. However, due to cumbersome and complicated preprocessing, it is presently di
Autor:
Rina Kimura, Tetsuhito Kojima, Yasuo Ikeda, Hiromi Okada, Shigenori Honda, Yukiko Sato, Etsuji Suehisa, Hajime Tsuji, Junko Ishikawa, Koichi Kokame, Tomio Kawasaki, Toshiyuki Miyata, Mitsuru Murata, Seiji Madoiwa, Satoshi Takeshita, Toshiyuki Sakata, Yoichi Sakata
Publikováno v:
Thrombosis Research. 124:14-18
Introduction Genetic deficiencies of PROS1, PROC, and SERPINC1 (antithrombin) are risk factors for deep vein thrombosis (DVT). Diagnosis of the inherited deficiencies of these three genes is sometimes difficult because of the phenotypic variability.
Publikováno v:
Blood Coagulation & Fibrinolysis. 19:597-600
We investigated the frequencies of coagulation factor deficiencies in a Japanese population. We measured factor II, V, VII and X activity in 100 healthy individuals. A specific factor deficiency was determined according to the factor activity and the
Autor:
Yumiko Masuda, Yuzuru Kanakura, Yoshinori Iwatani, Etsuji Suehisa, Toru Takano, Yoh Hidaka, Yoshiaki Futsukaichi, Junzo Nojima, Hirohiko Kuratsune, Yasuyoshi Watanabe
Publikováno v:
Biochemical and Biophysical Research Communications. 365:195-200
Our aim was to clarify the role of anti-phospholipid antibodies in the pathogenesis of monocyte tissue factor (TF) expression and thromboembolic complications (TE) in patients with SLE. We examined cell surface expression of TF on monocytes in 93 SLE
Autor:
Shoko Sugiyama, Etsuji Suehisa, Kazuhiro Nishigami, Tomio Kawasaki, Hitonobu Tomoike, Yoshihiro Kokubo, Rina Kimura, Hisao Hirota, Toshiyuki Miyata, Akira Okayama, Ichiro Kawase, Tokio Hayashi
Publikováno v:
Thrombosis Research. 119:35-43
Introduction Thrombomodulin (TM) is an essential cofactor in protein C activation by thrombin. Here, we evaluated the contribution of genetic variations in the TM gene to soluble TM (sTM) level and deep vein thrombosis (DVT) in Japanese. Patients and
Autor:
Seishi Asari, Eiji Kobayashi, Nori Yoshioka, Yoshinori Iwatani, Masanori Kagita, Matsuo Deguchi, Etsuji Suehisa, Yoh Hidaka, Mifumi Kita
Publikováno v:
Clinical laboratory. 61(1-2)
Background The determination of antibody to hepatitis B core antigen (HBcAb) has become an important means of evaluating the risk factors of de novo hepatitis B virus (HBV) infection before starting intensive immunosuppressive drug therapies. Four do
Autor:
Etsuji Suehisa, Teruo Kitani, Yuzuru Kanakura, Hirohiko Kuratsune, Junzo Nojima, Yoshinori Iwatani
Publikováno v:
Thrombosis and Haemostasis. 91:967-976
SummaryCerebral infarction is the most common arterial thromboembolic complication in the anti-phospholipid antibodies (aPL) syndrome. In an effort to clarify the roles of aPL in the pathogenesis of cerebral infarction in patients with SLE, we examin
Autor:
Junzo Nojima, Teruo Kitani, Yuzuru Kanakura, Takashi Machii, Tomio Kawasaki, Etsuji Suehisa, Hirohiko Kuratsune, Yoshinori Iwatani
Publikováno v:
British Journal of Haematology. 118:577-583
Venous thromboembolism (VTE) is one of the common manifestations in the anti-phospholipid (aPL) syndrome. We examined the levels of IgG antibodies (Abs) to beta2-glycoprotein I (beta2-GP I) and prothrombin, lupus anticoagulant (LA) activity, activate
Autor:
Junzo Nojima, Yoshinori Iwatani, Teruo Kitani, Hirohiko Kuratsune, Yuzuru Kanakura, Tomio Kawasaki, Etsuji Suehisa, Takashi Machii
Publikováno v:
Thrombosis and Haemostasis. 88:716-722
SummaryAnti-phospholipid (aPL) antibodies (Abs) are well known to be associated with thromboembolic events in patients with systemic lupus erythematosus (SLE). However, the clinical relevance of aPL Abs in patients without SLE (non-SLE) who have veno